Division of Neurology, The Hospital for Sick Children, Toronto, ON, Canada.
Dev Med Child Neurol. 2013 May;55(5):434-9. doi: 10.1111/dmcn.12092. Epub 2013 Feb 11.
To describe outcomes and outcome predictors in childhood basilar artery stroke (BAS).
We prospectively enrolled children with BAS with or without basilar artery occlusion (BAO) in the Toronto Children's Stroke Registry from 1992 to 2009. We assessed presenting features and outcomes including Pediatric Stroke Outcome Measure scores.
Among 578 children with acute arterial ischemic stroke, 27 had BAS (4.6% including neonates, 6% excluding neonates). Twenty-four (14 males, 10 females) children met study criteria (mean age at stroke was 8 y 10 mo; range 0-17 y). Eleven children had BAO. Aspirin or anticoagulation was given to 15 children. None received tissue plasminogen activator or endovascular treatments. At mean follow-up (3 y 2 mo, range 1 mo-11 y 8 mo), 12 had a 'good outcome' (seven normal, five insignificant deficit) and 12 had 'poor outcome' (10 moderate or severe deficit, two acute deaths). Larger infarct size (≥50% of axial brainstem diameter) independently predicted poor outcome (p=0.02; odds ratio 21.2, 95% confidence interval 1.6-274.9) but not BAO, altered level of consciousness, or age.
Compared with adults, in childhood BAS death is rare and survivors frequently have good outcomes. Aggressive endovascular interventions may not be justifiable in this population.
描述儿童基底动脉卒中(BAS)的结局和结局预测因素。
我们前瞻性纳入了 1992 年至 2009 年期间多伦多儿童卒中登记处的伴有或不伴有基底动脉闭塞(BAO)的 BAS 患儿。我们评估了包括儿科卒中结局量表评分在内的发病特征和结局。
在 578 例急性动脉缺血性卒中患儿中,有 27 例为 BAS(包括新生儿为 4.6%,不包括新生儿为 6%)。24 名(14 名男性,10 名女性)患儿符合研究标准(卒中时的平均年龄为 8 岁 10 个月;范围 0-17 岁)。11 名患儿存在 BAO。15 名患儿给予了阿司匹林或抗凝治疗。没有患儿接受组织型纤溶酶原激活物或血管内治疗。在平均随访(3 年 2 个月,范围 1 个月-11 年 8 个月)时,12 名患儿有“良好结局”(7 名正常,5 名无明显缺陷),12 名患儿有“不良结局”(10 名中重度缺陷,2 名急性死亡)。较大的梗死灶大小(≥50%的脑干轴径)独立预测不良结局(p=0.02;优势比 21.2,95%置信区间 1.6-274.9),但 BAO、意识改变或年龄不是。
与成人相比,儿童 BAS 死亡罕见,幸存者常预后良好。在该人群中,积极的血管内干预可能没有理由。